STAT3 and cancer: A number of anti-cancer compounds that inhibit STAT3 have been designed to date including Stattic[13, 14], the first direct small molecular inhibitor, as well as LLL12 [9], S31-201[10] and STA-21[15], in addition to the dual STAT3/STAT5 inhibitor SH-4-54[16].